Coronary Artery Disease in CKD-G5D Patients: An Update

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Patients with chronic kidney disease on dialysis (CKD-G5D) exhibit a high prevalence of coronary artery disease (CAD).
• This population differs from non-uremic patients with CAD and has been historically excluded from clinical trials.
• Asymptomatic CAD in CKD-G5D patients complicates risk stratification and management.

Purpose of the Study:

• To review the incidence, epidemiology, pathophysiology, screening tools, and management of CAD in CKD-G5D patients.
• To examine recent studies on screening tools and management strategies for CAD in this specific patient group.
• To emphasize the necessity for enhanced cardiovascular risk factor evaluation and early intervention for symptomatic CAD in CKD-G5D patients.

Main Methods:

• Literature review of existing studies on CAD in CKD-G5D patients.
• Analysis of recent research concerning screening tools and management strategies.
• Synthesis of epidemiological and pathophysiological data.

Main Results:

• CKD-G5D patients present unique challenges in CAD management due to differences from non-uremic populations.
• Current screening tools and management strategies require further evaluation for efficacy in this cohort.
• There is a clear need for improved methods to identify and treat CAD early in CKD-G5D patients.

Conclusions:

• Effective management of CAD in CKD-G5D patients requires tailored approaches.
• Further research is essential to optimize screening and intervention strategies.
• Early detection and treatment are crucial for improving outcomes in CKD-G5D patients with CAD.